|
Variables
|
2002–2006
|
2007–2011
|
|---|
| |
Anti-TNF (557)
|
DMARDs (1144)
|
Non-users (656)
|
Anti-TNF (690)
|
DMARDs (1651)
|
Non-users (532)
|
|---|
|
Demographics
|
|
Age (mean (±SD)) years
|
63.0(11.5)
|
64.2 (10.8)
|
65.1 (10.6)
|
65.2 (10.5)
|
66.2 (9.7)
|
68.4 (9.3)
|
|
Sex (female N (%))
|
426 (76.5)
|
921 (80.5)
|
562 (85.7)
|
517 (74.9)
|
1281 (77.6)
|
426 (80.1)
|
|
Residence (urban N (%))
|
428 (76.8)
|
899 (78.6)
|
526 (80.2)
|
531 (77.0)
|
1316 (79.7)
|
425 (79.9)
|
|
Higher incomea
|
344 (61.8)
|
691 (60.4)
|
379 (57.8)
|
417 (60.4)
|
980 (59.4)
|
339 (63.7)
|
|
Socioeconomic status N (%)
|
|
Social quintile 0
|
58 (10.4)
|
90 (7.9)
|
48 (7.3)
|
49 (7.1)
|
100 (6.1)
|
25 (4.7)
|
|
Social quintile 1
|
106 (19.0)
|
211 (18.4)
|
88 (13.4)
|
113 (16.4)
|
285 (17.3)
|
74 (13.9)
|
|
Social quintile 2–3
|
192 (34.5)
|
392 (34.3)
|
238 (36.3)
|
251 (36.5)
|
618 (37.4)
|
218 (41.0)
|
|
Social quintile 4–5
|
201 (36.1)
|
451 (39.4)
|
282 (43.0)
|
276 (40.0)
|
648 (39.2)
|
215 (40.4)
|
|
Use of health services in prior year N (%)
|
|
Visit to rheumatologist
|
490 (88.0)
|
946 (82.7)
|
480 (73.2)
|
608 (88.1)
|
1365 (82.7)
|
338 (63.5)
|
|
Comorbidity in prior year N (%)
|
|
Hematologic disorders
|
75 (13.5)
|
112 (9.8)
|
69 (10.5)
|
72 (10.4)
|
182 (11.0)
|
69 (13.0)
|
|
Heart failure
|
16 (2.9)
|
29 (2.5)
|
9 (1.4)
|
19 (2.8)
|
38 (2.3)
|
23 (4.3)
|
|
Cerebrovascular disease
|
21 (3.8)
|
23 (2.0)
|
19 (2.9)
|
10 (1.4)
|
39 (2.4)
|
22 (4.1)
|
|
Atrial fibrillation
|
14 (2.5)
|
24 (2.1)
|
13 (2.0)
|
23 (3.3)
|
54 (3.3)
|
18 (3.4)
|
|
Ischemic heart disease
|
79 (14.2)
|
138 (12.1)
|
76 (11.6)
|
65 (9.4)
|
186 (11.3)
|
56 (10.5)
|
|
Peptic ulcer disease
|
7 (1.3)
|
10 (0.9)
|
5 (0.8)
|
1 (0.1)
|
9 (0.5)
|
3 (0.6)
|
|
Cancer
|
39 (7.0)
|
102 (8.9)
|
51 (7.8)
|
69 (10.0)
|
172 (10.4)
|
64 (12.0)
|
|
Medication use in prior year N (%)
|
|
NSAIDs
|
430 (77.2)
|
843 (73.7)
|
452 (68.9)
|
435 (63.0)
|
980 (59.4)
|
248 (46.6)
|
|
Serotonin reuptake inhibitors
|
57 (10.2)
|
107 (9.4)
|
62 (9.5)
|
71 (10.3)
|
164 (9.9)
|
532 (9.6)
|
|
Gastroprotective agents
|
322 (57.8)
|
664 (58.0)
|
345 (52.6)
|
463 (67.1)
|
970 (58.8)
|
328 (61.7)
|
|
Antidiabetics
|
63 (11.3)
|
115 (10.1)
|
51 (7.8)
|
81 (11.7)
|
170 (10.3)
|
77 (14.5)
|
|
Corticosteroid
|
414 (74.3)
|
757 (66.2)
|
400 (61.0)
|
500 (72.5)
|
928 (56.2)
|
306 (57.5)
|
|
Anticoagulants
|
27 (4.8)
|
49 (4.3)
|
31 (4.7)
|
32 (4.6)
|
106 (6.4)
|
34 (6.4)
|
|
Antihypertensives
|
294 (52.8)
|
587 (51.3)
|
305 (46.5)
|
414 (60.0)
|
944 (57.2)
|
335 (63.0)
|
- aThose who do not receive any guaranteed income supplement
